Hemetron

Pre-Seed
hemetron.com Biotech & Healthcare Zürich, Switzerland
Total Funding Undisclosed
Latest Round Undisclosed Pre-Seed
Last Announced May 31, 2026
Investors Undisclosed
Decision Makers 2 Verified

About Hemetron

Hemetron offers a handheld blood testing device that measures biomarkers for at‑home health monitoring and remote result sharing.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Pre-Seed
Global Headquarters Zürich, Switzerland
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website hemetron.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Pre-Seed announced

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Hemetron.

Funding History

1 Round
Pre-Seed · May 31, 2026
Undisclosed

Founders & Leadership

1

Alexander Tanno

Founder

Work email & phone locked Unlock →

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts